Warrant exercise registered at the Danish Companies Registration Office
PRESS RELEASE 18 December 2020 Initiator Pharma A/S (“Initiator Pharma” or “the Company”) yesterday announced the outcome of the exercise of the Company's warrants of series TO 2. Registration of the warrant exercise at the Danish Companies Registration Office has now taken place and the total number of shares amounts to 27,381,614 and the share capital to DKK 2,875,069.47. The date for conversion from interim shares to shares is 30 December 2020 and new shares are expected to be in each subscriber's account around 5 January 2021.For further information about Initiator